Bridgewater Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.5M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $207K | Sell |
|
|||||
|
2024
Q3 | $418K | Buy |
|
|||||
|
2024
Q2 | $359K | Sell |
|
|||||
|
2024
Q1 | $658K | Sell |
|
|||||
|
2023
Q4 | $763K | Sell |
|
|||||
|
2023
Q3 | $1.98M | Sell |
|
|||||
|
2023
Q2 | $1.75M | Sell |
|
|||||
|
2023
Q1 | $2.15M | Sell |
|
|||||
|
2022
Q4 | $2.82M | Sell |
|
|||||
|
2022
Q3 | $3.58M | Sell |
|
|||||
|
2022
Q2 | $3.65M | Sell |
|
|||||
|
2022
Q1 | $5.08M | Buy |
|
|||||
|
2021
Q4 | $4.16M | Buy |
|
|||||
|
2021
Q3 | $2.68M | Buy |
|
|||||
|
2021
Q2 | $2.39M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $508K | Buy |
|
|||||
|
2018
Q2 | $516K | Hold |
|
|||||
|
2018
Q1 | $362K | Sell |
|
|||||
|
2017
Q4 | $525K | Hold |
|
|||||
|
2017
Q3 | $488K | Hold |
|
|||||
|
2017
Q2 | $920K | Buy |
|
|||||
|
2017
Q1 | $793K | Hold |
|
|||||
|
2016
Q4 | $895K | Hold |
|
|||||
|
2016
Q3 | $1.14M | Hold |
|
|||||
|
2016
Q2 | $1.24M | Hold |
|
|||||
|
2016
Q1 | $1.32M | Buy |
|
|||||
|
2015
Q4 | $1.58M | Buy |
|